Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | Tunlametinib |
Trade Name | |
Synonyms | HL-085|HL085|HL 085 |
Drug Descriptions |
Tunlametinib (HL-085) is a MEK inhibitor that may inhibit proliferation of tumor cells (Cancer Res 2019;79(13 Suppl):Abstract nr 4753). |
DrugClasses | MEK inhibitor (Pan) 24 |
CAS Registry Number | 1801756-06-8 |
NCIT ID | C173437 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
OKI-005 + Tunlametinib | OKI-005 Tunlametinib | 0 | 0 |
Tunlametinib | Tunlametinib | 6 | 2 |
Tunlametinib + Vemurafenib | Tunlametinib Vemurafenib | 2 | 0 |